Clinical TrialsSearch results
Number of results: 595
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Phase1/2 study of endoscopic photodynamic therapy using ME2906 and ultrathin PDT probe in unresectable bile duct cancer
- Unresectable bile duct cancer
- Sato Junya
- 2023-01-16
Other
- Evaluation of the efficacy of proton pump inhibitor for postoperative delirium after hepatobiliary and pancreatic surgery
- Hepatectomy or pancreatectomy for diseases of the liver, biliary tract, pancreas, and duodenum
- Sugiura Teiichi
- 2022-12-27
Recruiting
- A phase II study of consolidative radiotherapy for residual lesions during osimertinib monotherapy (ORIHALCON trial/WJOG13920L)
- Non-small cell lung cancer
- Kenmotsu Hirotsugu
- 2022-12-27
Recruiting
- Phase II study of Ninjin'yoeito for anorexia in patients with advanced non-small-cell lung cancer
- Advanced non-small-cell lung cancer
- Naito Tateaki
- 2022-12-09
Not yet recruiting
- Development of echocardiography-guid AI to aid echocardiography acquisition
- none
- Saito Takeji
- 2022-11-17
Recruiting
- The Neural Basis of Higher-Order Cognitive Development in Childhood: An Investigation Using Functional Near Infrared Spectroscopy (fNIRS)
- Typical development
- HARADA Taeko
- 2022-10-18
Completed
- Extension Study following the studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects with Amyotrophic Lateral Sclerosis (ALS)
- Amyotrophic Lateral Sclerosis
- Kazuoki Kondo
- 2022-10-07
Recruiting
- Relations between autistic traits, myopic memory style of unpleasant event and secondary difficulties.
- Autistic traits
- Senju Atsushi
- 2022-09-14
Completed
- Effects on Respiratory Compliance with Sugammadex in Children on Ventilation
- Persons undergoing surgery under general anesthesia
- Yagihara Masahiro
- 2022-08-30
Other
- Placebo-controlled comparative study of NPC-12Y oily gel in patients with skin lesions associated with tuberous sclerosis complex
- Tuberous Sclerosis Complex
- Fujimoto Ayataka
- 2022-08-10